Skip to content
healthcare.dev

ARANESP

NDC 55513-005, darbepoetin alfa, solution, from Amgen, Inc.

Product NDC
55513-005
Status
Listed
Labeler
Amgen, Inc
Dosage form
SOLUTION
Route
INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA103951
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55513-005 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DARBEPOETIN ALFA100 ug/mL

Pharmacologic classes

Erythropoiesis-stimulating Agent [EPC]; Erythropoietin [CS]; Increased Erythroid Cell Production [PE]

Package NDCNDC-11Package
55513-005-04555130005044 VIAL, SINGLE-DOSE in 1 PACKAGE (55513-005-04) / 1 mL in 1 VIAL, SINGLE-DOSE (55513-005-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/0fd36cb9-c4f6-4167-93c9-8530865db3f9
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=55513-005

Use it

Look up 55513-005 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55513-005 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55513-005. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.